Waltham, MA – The Boston office of Cresa, an occupier-focused commercial real estate firm, and Newmark, a provider of commercial real estate services, announced the negotiation of a 22,000sf lease at Stony Brook in Waltham.
The lease at 130 Turner Street is on behalf of Olink Proteomics, a Swedish company that provides products and services for human protein biomarker discovery. Olink’s new life science space, delivering in Q3 2021, is a five-minute walk to the Brandeis-Roberts MBTA commuter rail station, three stops from the Porter Square MBTA red line, and minutes from the intersection of 1-90 and 1-95.
Stony Brook Park has actively embarked on a life science conversion of approximately 100,000sf. This three-building campus, owned by Jumbo Capital/SoundMark Partners, recently underwent an overhaul to its amenities in 2020 in anticipation of capturing new life science and office tenants.
Following a competitive process, Cresa was selected by Olink for transaction management and project management services as it sought new office, research, and laboratory space. Paul Delaney and John Coakley at Cresa Boston negotiated the lease for Olink, and the Cresa team is overseeing an aggressive schedule so the company can relocate from its current 7,000sf in Watertown to Waltham in mid-September. The Newmark team, led by Managing Director Matt Malatesta, Executive Managing Director Mark Roth, Managing Director Brendan Daly and Associate Brianna Piacitelli, represented the owner, Jumbo Capital, in the property lease to Olink.
The design of the lab by MDS/Miller Dyer Spears draws from a Scandinavian aesthetic, emphasizing functionality and supporting Olink’s core values of innovation, quality, rigor, and transparency. The lab is organized around a central “living room” area, surrounded by offices, shared work spaces, lab, and freezer farm. A large communal table, soft seating and kitchenette define the living room, designed as a welcoming, collegial space for collaboration and interaction.
The project team also includes MDS/Miller Dyer Spears, architect; PIDC Construction, construction manager; AHA Consulting Engineers Inc., MEP engineer; COP and DIRTT, office furniture; and DGI, AV.
“We were looking for a partner to assist us in finding the right real estate solution,” said Bill Campbell, PhD, vice president of Global Commercial Operations at Olink. “Cresa Boston has been our trusted advisor from the very start, asking the right questions to ensure we achieved our goals and objectives with our relocation. Stony Brook was an excellent solution for life science due to the excellent attributes like direct access, Red Line accessibility, and strong ownership.”
“Olink will be well-positioned to grow its business and continue its groundbreaking work in this first-class life science facility,” said Malatesta. “With flexible spaces, proximity to a major university and public transit access, the campus will continue to see interest from life science users. This will be a catalyst for future lab opportunities on site.”
Waltham remains one of Greater Boston’s premier suburban life science markets, according to Newmark Research. With close to 3.0 million sq. ft. in lab space, Waltham inventories have more than doubled in the last five years. Availabilities have been declining as the relative lack of space within Cambridge continues to push lab demand into markets like Waltham. Following several quarters of strong leasing activity total availabilities reached just 7.6% in the first quarter of 2021.